Sun Pharma to Acquire Concert Pharmaceuticals Sun Pharma to Acquire Concert Pharmaceuticals
TUESDAY, JANUARY 24, 2023
Sun Pharmaceutical and Concert Pharmaceuticals announced on Monday that they have executed an agreement under which Sun Pharma will acquire all outstanding shares of Concert through a tender offer for an upfront payment of $8.00 per share of common stock in cash, or $576 million in equity value.